Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial
- PMID: 12417544
- DOI: 10.1161/01.cir.0000037224.15873.83
Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial
Abstract
Background: Fifty percent of deaths in patients with coronary disease occur suddenly. Although many factors correlate with increased mortality, there is little information regarding the influence of these factors on mode of death. As such, optimum methods to determine patients most likely to benefit from implantable defibrillator therapy are unclear.
Methods and results: We analyzed the relation of ejection fraction and inducible ventricular tachyarrhythmias to mode of death in all 1791 patients enrolled in the Multicenter Unsustained Tachycardia Trial who did not receive antiarrhythmic therapy. Total mortality and arrhythmic deaths/cardiac arrests occurred more frequently in patients with ejection fraction <30% than in those with ejection fraction of 30% to 40%. The percentage of deaths classified as arrhythmic was similar in patients with ejection fraction <30% or > or =30%. The relative contribution of arrhythmic events to total mortality was significantly higher in patients with inducible tachyarrhythmia (58% of deaths in inducible patients versus 46% in noninducible patients, P=0.004). The higher percentage of events that were arrhythmic among patients with inducible tachyarrhythmia appeared more distinct among patients with an ejection fraction > or =30% (61% of events were arrhythmic among inducible patients with ejection fraction > or =30% and only 42% among noninducible patients, P=0.002).
Conclusions: Both low ejection fraction and inducible tachyarrhythmias identify patients with coronary disease at increased mortality risk. Ejection fraction does not discriminate between modes of death, whereas inducible tachyarrhythmia identifies patients for whom death, if it occurs, is significantly more likely to be arrhythmic, especially if ejection fraction is > or =30%.
Comment in
-
Treating Chlamydia pneumoniae in patients with early atherosclerosis.Circulation. 2002 Nov 5;106(19):e9047-8. doi: 10.1161/01.cir.0000045980.20226.b3. Circulation. 2002. PMID: 12417556 No abstract available.
Similar articles
-
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.J Am Coll Cardiol. 2007 Sep 18;50(12):1150-7. doi: 10.1016/j.jacc.2007.04.095. Epub 2007 Sep 4. J Am Coll Cardiol. 2007. PMID: 17868806 Clinical Trial.
-
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.N Engl J Med. 2000 Jun 29;342(26):1937-45. doi: 10.1056/NEJM200006293422602. N Engl J Med. 2000. PMID: 10874061 Clinical Trial.
-
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).Am J Cardiol. 2007 Jul 1;100(1):76-83. doi: 10.1016/j.amjcard.2007.02.055. Epub 2007 May 11. Am J Cardiol. 2007. PMID: 17599445 Free PMC article. Clinical Trial.
-
New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. doi: 10.1016/s0002-9149(99)00040-5. Am J Cardiol. 1999. PMID: 10089848 Review.
-
Screening and therapy for patients with nonsustained ventricular tachycardia.Am J Cardiol. 2000 Nov 2;86(9A):34K-39K. doi: 10.1016/s0002-9149(00)01290-x. Am J Cardiol. 2000. PMID: 11084098 Review.
Cited by
-
Factors likely to affect the long-term results of ventricular stimulation after myocardial infarction.Indian Pacing Electrophysiol J. 2010 Apr 1;10(4):162-72. Indian Pacing Electrophysiol J. 2010. PMID: 20376183 Free PMC article.
-
Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials.Clin Res Cardiol. 2008 Sep;97(9):594-600. doi: 10.1007/s00392-008-0656-7. Epub 2008 Mar 17. Clin Res Cardiol. 2008. PMID: 18347765
-
T-wave alternans for risk stratification and prevention of sudden cardiac death.Curr Cardiol Rep. 2003 Sep;5(5):350-7. doi: 10.1007/s11886-003-0090-4. Curr Cardiol Rep. 2003. PMID: 12917048 Review.
-
Increased inducibility of ventricular tachycardia and decreased heart rate variability in a mouse model for type 1 diabetes: effect of pravastatin.Am J Physiol Heart Circ Physiol. 2013 Dec;305(12):H1807-16. doi: 10.1152/ajpheart.00979.2012. Epub 2013 Oct 25. Am J Physiol Heart Circ Physiol. 2013. PMID: 24163078 Free PMC article.
-
Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view.J Cardiovasc Med (Hagerstown). 2016 Apr;17(4):245-55. doi: 10.2459/JCM.0000000000000368. J Cardiovasc Med (Hagerstown). 2016. PMID: 26895401 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials